Compliance with the urine marker PABAcheck in cancer epidemiology studies.
Runswick
S
S
Institute of Public Health, Cambridge, UK.
Slothouber
B
B
Boeing
H
H
Bueno-de-Mesquita
H
H
Clavel
F
F
Key
T
T
Ocke
M
M
Palli
D
D
Trichopoulou
A
A
Tumino
R
R
Slimani
N
N
Riboli
E
E
Powles
J
J
Subar
A
A
Bingham
S
S
D010129:4-Aminobenzoic Acid / Q000008:administration & dosage / Q000652:urine*; D015415:Biomarkers / Q000652:urine; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D015331:Cohort Studies; D003124:Colorimetry / Q000379:methods; D016021:Epidemiologic Studies; D005060:Europe; D006801:Humans; D009584:Nitrogen / Q000652:urine; D010349:Patient Compliance; D011188:Potassium / Q000652:urine; D011446:Prospective Studies; D014481:United States; D016482:Urinalysis
D015415:Biomarkers; D009584:Nitrogen; D011188:Potassium; D010129:4-Aminobenzoic Acid